Drug Trial Radar · NCT07778836
A Study to Evaluate the Efficacy and Safety of Subcutaneous Nomlabofusp in Subjects With Friedreich's Ataxia
Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Aug 5, 2026
Primary completion
Jul 2029
Study completion Dec 2029
Sponsor
- Lead sponsor
- Larimar Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 21, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the efficacy and safety of subcutaneous nomlabofusp in adult and pediatric subjects with Friedreich's ataxia
Conditions
- Friedreich Ataxia
- Friedreich's Ataxia
Interventions
NomlabofuspDrug
Nomlabofusp is a recombinant fusion protein provided in a sterile, preservative-free buffered solution for subcutaneous injection intended to deliver human frataxin, the protein deficient in Friedreich's ataxia.
PlaceboDrug
The placebo is a sterile, preservative-free, clear liquid for subcutaneous injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in Upright Stability Score (USS) subscale E of modified Friedreich's Ataxia Rating Scale (mFARS) at Week 72 (Region-specific)Time frame: Baseline, Weeks 12, 24, 36, 48, 72
- Change from baseline in the total modified Friedreich's Ataxia Rating Scale (mFARS) at Week 72 (Region-specific)Time frame: Baseline, Weeks 12, 24, 36, 48, 72
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Morsani Center for Advanced Health Care, University of South Florida Health
Tampa, Florida · Recruiting
Northwestern Medical Group, Department of Neurology
Chicago, Illinois · Recruiting
Clinilabs
Eatontown, New Jersey · Recruiting
University of Texas Southwestern Medical Center
Dallas, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.